Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia

Journal of Pharmacology and Experimental Therapeutics

Volumn 284, Issue 3, 1998, Pages 1180-1187

  Costerousse, Olivier ^a   Allegrini, Jacqueline ^a   Clozel, Jean Paul ^b   Ménard, Joël ^a   Alhenc Gelas, François ^a  

^a INSERM   (France)

^b Hoffmann La Roche   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CILAZAPRIL; CIPROKIREN; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; ENALAPRIL MALEATE; MESSENGER RNA;

ANIMAL EXPERIMENT; AORTA; ARTICLE; DOSE TIME EFFECT RELATION; DRUG EFFECT; ENZYME INDUCTION; ENZYME SYNTHESIS; GENE EXPRESSION REGULATION; HORMONAL REGULATION; INTESTINE MUCOSA; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TISSUE DISTRIBUTION;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ENALAPRIL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GUINEA PIGS; HUMANS; LOSARTAN; MALE; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, WISTAR; RECEPTORS, ANGIOTENSIN; RENIN; RNA, MESSENGER;

EID: 0031888250     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. André P, Schott C, Nehlig H and Stoclet JC (1990) Aortic smooth muscle cells are able to convert angiotensin I to II. Biochem Biophys Res Commun 173:1137-1142.
2. Arnal JF, Battle T, Rasetti C, Challah M, Costerousse O, Vicaut E, Michel JB and Alhenc-Gelas F (1994) ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am J Physiol 267:H1777-H1784.
3. Azizi M, Rousseau A, Elan E, Guyenne TT, Michelet S, Grognet JM, Lenfant M, Corvol P and Ménard J (1996) Acute ACE inhibition increases the plasma level of the natural stem cell regulator N acetyl-seryl-aspartyl-lysyl-proline. J Clin Invest 97:588-592.
4. Barbu V and Dautry F (1989) Northern blot normalization with a 28S rRNA oligonucleotide probe. Nucleic Acids Res 17:7115.
5. Berecek KH, King SJ, Wu SN, Oparil S, Rydzewski B and Raizada M (1992) Effects of angiotensin II (AII) in the presence and absence of subtype-specific AII blockers on ACE gene expression in central nervous system tissue (abstract). FASEB J 6:A1578.
6. Boomsma F, DeBruyn JHB, Derkx FHM, Schalekamp MADH (1981) Opposite effects of captopril on angiotensin I-converting enzyme activity and concentration, relation between enzyme inhibition and long-term blood pressure response. Clin Sci 60:491-498.
7. Bradford M (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
8. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, Rakotovao R, Ducimetiere P, Soubrier F and Alhenc-Gelas F (1994) Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 90:669-676.
9. Cambien F, Poirier O, Lecerf L, Evans AE, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S, Tiret L, Amouyel P, Alhenc-Gelas F and Soubrier F (1992) Deletion polymorphism at the ACE gene is a potent risk factor for myocardial infarction. Nature 359:641-644.
10. Chomczynski P and Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
11. Clozel JP, Hess P, Schietinger K, Breu V, Fischli W and Baumgartner HR (1994) Major role of the renin angiotensin system in the neointima formation after vascular injury in guinea pigs. Life Sci 54:87-92.
12. Costerousse O, Allegrini J, Huang H, Bounhik J and Alhenc-Gelas F (1994) Regulation of ACE gene expression and plasma levels during rat postnatal development. Am J Physiol 267:E745-E753.
13. Costerousse O, Allegrini J, Lopez M and Alhenc-Gelas F (1993) Angiotensin I. converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T lymphocytes. Biochem J 290:33-40.
14. Cushman DW and Cheung HS (1971) Spectrophotometric assay and properties of the angiotensin converting enzyme of rabbit lung. Biochem Pharmacol 20:1637-1648
15. Cushman DW and Cheung HS (1971) Concentrations of angiotensin-converting enzyme in tissues of rat. Biochim Biophys Acta 250:261-265.
16. Cushman DW and Ondetti MA (1980) Inhibitors of angiotensin-converting enzyme. Prog Med Chem 17:42-104.
17. Damas J and Adam A (1980) Congenital deficiency in plasma kallikrein and kininogens in the brown Norway rat. Experientia 36:586-587.
18. Durnam DM and Palmiter RD (1983) A practical approach for quantitating specific mRNAs by solution hybridization. Anal Biochem 131:385-393.
19. Ehlers MrW, Fox EA, Strydom DJ and Riordan JF (1989) Molecular cloning of human testicular angiotensin-converting enzyme: The testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc Natl Acad Sci USA 86:7741-7745.
20. Erdos EG (1990) Angiotensin I-converting enzyme and the changes in our concept through the years. (Lewis K. Dahl memorial lecture). Hypertension 16:363-370
21. Fyhrquist F, Forslund T, Tikkanen I and Grönhagen-Riska C (1980) Induction of angiotensin converting enzyme in rat lung with captopril (SQ14225). Eur J Pharmacol 67:473-475.
22. Fyhrquist F, Hortung L and Grönhagen-Riska C (1982) Induction of angiotensin converting enzyme by captopril in cultured human endothelial cells. J Clin Endocrinol Metab 55:783-786.
23. Hayashi I, Hoshiko S, Makabe O and Ohishi S (1993) A point mutation of alanine 163 to threonine is responsible for the defective secretion of high molecular weight kininogen by the liver of brown Norway Katholiek rats. J Biol Chem 268:17219-17224.
24. Howard TE, Shai SY, Langford KG, Martin BM and Bernstein KE (1990) Transcription of testicular angiotensin-converting enzyme is initiated within the 12th intron of the somatic ACE gene. Mol Cell Biol 10:4294-4302.
25. Jackson B, Cubela R and Johnston C (1986) Angiotensin converting enzyme, characterization by I125-MK351A binding studies of plasma and tissue ACE during variation of salt status in rats. J Hypertension 4:759-765.
26. Johns DW, Peach MJ, Gomez RA, Inagami T and Carey RM (1990) Angiotensin II regulates renin gene expression. Am J Physiol 259:F882-F887.
27. Johnston CI (1992) Renin-angiotensin system: A dual tissue and hormonal system for cardiovascular control. J Hypertens 10: suppl 7, S13-S26.
28. Juillerat L, Nussberger J, Ménard J, Mooser V, Christen Y, Waeber B, Graf P and Brunner HR (1990) Determinants of angiotensin II generation during converting enzyme inhibition. Hypertension 16:564-572.
29. Kessler M, Acuto O, Storelli C, Murer H, Muller M and Semenza G (1978) A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Biochim Biophys Acta 506:136-154.
30. King SJ and Oparil S (1992) Converting enzyme inhibitors increase converting enzyme mRNA and activity in endothelial cells. Am J Physiol 263:C743-C749.
31. Kohara K, Brosnihan KB, Ferrario CM and Milsted A (1992) Peripheral and central angiotensin II regulates expression of genes of the renin-angiotensin system. Am J Physiol 262:E651-E657.
32. Kohzuki M, Johnston CI, Chai SY, Jackson B, Perich R, Paxton D and Mendelsohn FA (1991) Measurement of angiotensin converting enzyme induction and inhibition using quantitative in uitro autoradiography: Tissue selective induction after chronic lisinopril treatment. J Hypertens 9:579-587.
33. Kumar RS, Kusari J, Roy SN, Soffer RL and Sen GC (1989) Structure of testicular angiotensin-converting enzyme: A segmental mosaic isozyme. J Biol Chem 264: 16754-16758.
34. Larochelle P, Genest J, Kuchel O, Boucher R, Gutkowska Y and McKinstry D (1979) Effect of captopril on blood pressure, plasma renin activity and angiotensin I converting enzyme activity. Can Med Assoc J 121:309-313.
35. Lassegue B, Alexander RW, Nickening G, Clark M, Murphy TJ and Griendling KK (1995) Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: Evidence for homologous and heterologous regulation. Mol Pharmacol 48:601-609.
36. Lattion AL, Soubrier F, Allegrini J, Hubert C, Corvol P and Alhenc-Gelas F (1989) The testicular transcript of the angiotensin I-converting enzyme encodes for the ancestral non-duplicated form of the enzyme. FEBS Lett 252:99-104.
37. Lewis EJ, Hunsicker LG, Bain RP and Rohde RD (1993) The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy: The Collaborative Study Group. N Engl J Med 329:1456-1462.
38. Lonn EM, Yusuf S, Montague TJ, Teo KK, Benedict CR and Pitt B (1994) Emerging role of ACE inhibitors in cardiac and vascular protection. Circulation 90:2056-2069.
39. Margolius HS (1995) Theodore Cooper Memorial Lecture: Kallikreins and kinins: Some unanswered questions about system characteristics and roles in human disease. Hypertension 26:221-229.
40. Marre M, Bernardet P, Gallois Y, Savagner F, Guyenne TT, Hallab M, Cambien F, Passa P and Alhenc-Gelas F (1994) Relationships between angiotensin I-converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388.
41. Marre M, Leblanc H, Suarez L, Guyenne TT, Ménard J and Passa P (1987) Converting enzyme inhibition and kidney function in normotensive diabetic patients With persistent microalbuminuria. BMJ 294:1448-1452.
42. Maschio G, Alberti D, Janin G, Locatelli F, Mann JfE, Motolese M, Ponticelli C, Ritz E and Ziuchelli P (1996) ACE inhibition in progressive renal insufficiency study group: Effect of the ACE inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945.
43. Ménard J and Catt KJ (1972) Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology 90:422-430.
44. Patchett AA, Harris E, Tristram EW, Wyvratt MJ, Wu MT, Taub D, Peterson ER, lkeler TJ, Ten Broeke J, Payne LG, Ondeyka DL, Thorsett ED, Greenlee WJ, Lohr NS, Hoffsommer RD, Joshua H, Ruyle WV, Rothrock JW, Aster SD, Maycock AL, Robinson FM, Hirshmann R, Sweet CS, Ulm EH, Gross DM, Vassil TC and Stone CA (1980) A new class of angiotensin-converting enzyme inhibitors. Nature 288: 280-283.
45. Pfeffer MA, Braunwald E, Moye LA, Basta L, Brown EJ, Cuddy TE, Davies BR, Geltman EM, Goldman S and Flaker GC (1992) Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: Results of the Survival and Ventricular Enlargement Trial. N Engl J Med 327:669-677.
46. Reis ML, Alhenc-Gelas F, Alhenc-Gelas M, Allegrini J, Kerbiriou-Nabias D, Corvol P and Ménard J (1985) Rat high-molecular-weight kininogen: Purification, production of antibodies and demonstration of lack of immunoreactive kininogen in a strain of Brown Norway rats. Biochim Biophys Acta 831:106-113.
47. Sassano P, Chatellier G, Billaud E, Alhenc-Gelas F, Corvol P and Ménard J (1987) Treatment of mild to moderate hypertension with or without the converting enzyme inhibitor enalapril. Am J Med 83:227-235.
48. Schmaier AH, Kuo A, Lundberg D, Murray S and Cines DB (1988) The expression of high molecular weight kininogen on human umbilical vein endothelial cells. J Biol Chem 263:16327-16333.
49. Schunkert H, Ingelfinger JR, Hirsch AT, Pinto Y, Remme WJ, Jacob H and Dzau VJ (1993) Feedback regulation of angiotensin converting enzyme activity and mRNA levels by angiotensin II. Circ Res 72:312-318.
50. Sibony M, Gasc JM, Soubrier F, Alhenc-Gelas F and Corvol P (1993) Gene expression and tissue localization of the two isoforms of ACE. Hypertension 21:827-835.
51. Song GB, Tominaga M, Kanayama Y, Ikemoto F and Yamamoto K (1988) Enhancement of angiotensin I-converting enzyme activity in the inner cortex of rat kidney by captopril. Renal Physiol Biochem 11:43-49.
52. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G and Corvol P (1988) Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 85:9386-9390.
53. Swedberg K, Held P, Kjekshus J, Rasmussen K, Ryden L and Wedel H (1992) Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction: Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II). N Engl J Med 327:678-684.
54. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA and Smith RD (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45:205-251.
55. Wei L, Clauser E, Alhenc-Gelas F and Corvol P (1992) The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J Biol Chem 267:13398-13404.
56. Wiemer G, Scholkens BA, Becker RHA AND Busse R (1991) Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 18:558-563.